MedTrace Logo

Study of Effectiveness of GEMDOX in Relapsed Osteosarcoma

NCT04651179 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 33

Last updated 2021-11-26

No results posted yet for this study

Summary

A retrospective observational study of the effectiveness of gemcitabine - docetaxel in patients with relapsed osteosarcoma who have been treated with HD IFO in first line treatment

Conditions

  • Osteosarcoma Recurrent
  • Osteosarcoma Metastatic

Interventions

OTHER

observation

not applicable, observational study

Sponsors & Collaborators

  • Azienda Ospedaliera Ospedale Infantile Regina Margherita Sant'Anna

    lead OTHER

Principal Investigators

  • Franca Fagioli, MD · AOU Città della Salute e della Scienza di Torino - Presidio Infantile Regina Margherita

Eligibility

Min Age
4 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-04-24
Primary Completion
2021-06-06
Completion
2021-11-23

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04651179 on ClinicalTrials.gov